Pfizer Inc.

PFE

$41.49

+17.7% (1 year change)

Ken Fisher Holding value: $102 Million Jim Simons Holding value: $98.1 Million Jeremy Grantham Holding value: $31.6 Million Ken Griffin Holding value: $29.4 Million Joel Greenblatt Holding value: $19.8 Million Prem Watsa Holding value: $16.6 Million Mario Gabelli Holding value: $8.77 Million Ray Dalio Holding value: $6.69 Million Tom Russo Holding value: $0 Daniel Loeb Holding value: $0 David Einhorn Holding value: $0 Chris Davis Holding value: $0 Stanley Druckenmiller Holding value: $0 George Soros Holding value: $0 Bill Gates Holding value: $0 Donald Yacktman Holding value: $0 David Tepper Holding value: $0 Warren Buffett Holding value: $0

Market Cap

$234 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$32.74 - $51.86

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

17.66x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$1.53 (3.67%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $234 Billion
Enterprise Value $260 Billion
Dividend Yield $1.53 (3.67%)
1 Year Return +21.3%
52-Week High $51.86
52-Week Low $32.74
Beta 0.48
Outstanding Shares 5.61 Billion
Avg 30 Day Volume 24.5 Million

Valuation

P/E Ratio 17.66
PEG 28.32
Earnings per Share $2.34
Price to Sales Ratio 4.61
Price to Book Ratio 3.46
Revenue to Enterprise Value 5.03
EBIT to Enterprise Value 20.41
Total Debt to Enterprise Value 0.15
Debt to Equity 0.58

Profitability

Revenue $51.6 Billion
Gross Profit $36.3 Billion
EBIT $12.7 Billion
Net Income $13.2 Billion
Profit Margin 25.61%
Quarterly Earnings Growth (YoY) +62.4%
Return on Equity 19.28%
Return on Assets 8.33%
Return on Invested Capital 9.63%

Insider trades

No purchases

No sells

No purchases

2,500 shares sold (1 transactions)

No purchases

No sells

No purchases

No sells

Q1 2021 Q2 2021 Q3 2021 Q4 2021

About Pfizer Inc.

CEO: Albert Bourla

Industry: Pharmaceutical Preparation Manufacturing

Similar stocks

Merck & Co Inc
Johnson & Johnson
Lilly(Eli) & Co
Novartis AG - ADR
Glaxosmithkline plc - ADR
AMGEN Inc.
Abbott Laboratories
Astrazeneca plc - ADR

News

Pakistan reports lowest Covid-related deaths since July 22

Pakistan reports lowest Covid-related deaths since July 22

Pakistan reported 11 deaths on October 17, the lowest number since July 22, when the same number of fatalities were recorded. During the last 24 hours, Khyber Pakhtunkhwa reported three deaths from...

Business Recorder Business Recorder, about 16 hours ago
How young Sydneysiders jabbed their way out of lockdown with AstraZeneca

How young Sydneysiders jabbed their way out of lockdown with AstraZeneca

Melburnians'' reliance on Pfizer rather than the Australian manufactured AstraZeneca jab has contributed to their world record breaking lockdown.

Daily Mail Online Daily Mail Online, 1 day ago
Pfizer and BioNtech submit data to EMA for the approval of use of their Covid-19 vaccine in 5 to 12 year olds

Pfizer and BioNtech submit data to EMA for the approval of use of their Covid-19 vaccine in 5 to 12 year olds

Pfizer and BioNtech have submitted data to the European Medicines Agency for approval of the use of their Covid-19 vaccine in children aged between 5 and 12 years of age. In announcement the compan...

The Liberal The Liberal, 3 days ago
To improve your user experience we use cookies.